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Altering dietary carbohydrate (CHO) intake modulates fuel utilization during 52 
exercise. However, there has been no systematic evaluation of metabolic 53 
responses to graded changes in short-term (< 1 week) dietary CHO intake. 54 
Thirteen active men performed interval running exercise combined with 55 
isocaloric diets over 3 days before evaluation of metabolic responses to 60-56 
min running at 65% V̇O2max on three occasions. Diets contained lower (LOW, 57 
2.40 ± 0.66 g CHO.kg-1.d-1, 21.3 ± 0.5% of energy intake [EI]), moderate 58 
(MOD, 4.98 ± 1.31 g CHO.kg-1.d-1, 46.3 ± 0.7% EI), or higher (HIGH, 6.48 ± 59 
1.56 g CHO.kg-1.d-1, 60.5 ± 1.6% EI) CHO. Pre-exercise muscle glycogen 60 
content was lower in LOW (54.3 ± 26.4 mmol.kg-1 wet weight [ww]) compared 61 
to MOD (82.6 ± 18.8 mmol.kg-1 ww) and HIGH (80.4 ± 26.0 mmol.kg-1 ww, 62 
P<0.001; MOD vs. HIGH, P=0.85). Whole-body substrate oxidation, systemic 63 
responses, and muscle substrate utilization during exercise indicated 64 
increased fat and decreased CHO metabolism in LOW (RER: 0.81 ± 0.01) 65 
compared to MOD (RER 0.86 ± 0.01, P = 0.0005) and HIGH (RER: 0.88 ± 66 
0.01, P < 0.0001; MOD vs. HIGH, P=0.14). Higher basal muscle expression of 67 
genes encoding proteins implicated in fat utilization was observed in LOW. In 68 
conclusion, muscle glycogen availability and subsequent metabolic responses 69 
to exercise were resistant to increases in dietary CHO intake from ~5.0 to 70 
~6.5 g CHO.kg-1.d-1 (46% to 61% EI), while muscle glycogen, gene 71 
expression and metabolic responses were sensitive to more marked 72 
reductions in CHO intake (~2.4 g CHO.kg-1.d-1, ~21% EI). 73 
 74 
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Running head: Exercise metabolism following graded carbohydrate intake 77 
 78 
New and noteworthy 79 
The data presented here suggests that metabolic responses to steady-state 80 
aerobic exercise are somewhat resistant to short-term changes in dietary 81 
carbohydrate (CHO) intake within the 5-6.5 g CHO.kg-1.d-1 (46-61% EI) range. 82 
In contrast, reduction in short-term dietary CHO intake to ~2.4 g CHO.kg-1.d-1 83 
(21% EI) evoked clear changes indicative of increased fat and decreased 84 
CHO metabolism during exercise.  85 




Glycogen is the storage form of carbohydrate (CHO) energy in animals, 87 
primarily located in skeletal muscles and the liver (17, 34). Glycogen 88 
availability is sensitive to exercise and nutrition (4, 29, 35, 45), and glycogen 89 
depletion has been implicated in fatigue during prolonged moderate-to-90 
vigorous intensity exercise (31, 33, 34). Muscle glycogen is also recognised 91 
as a potent regulator of acute substrate metabolism during prolonged exercise 92 
(18), and is increasingly implicated in the regulation of exercise training 93 
adaptation (6, 20, 22). Therefore, understanding the precise relationship 94 
between nutrition, muscle glycogen availability, and metabolic responses to 95 
exercise has relevance for exercise performance, training adaptation, and 96 
health.    97 
 98 
Short-term (i.e., ≤1 week) dietary interventions that reduce CHO intake and 99 
lower muscle glycogen content elicit increased fatty acid and reduced CHO 100 
oxidation during subsequent moderate-intensity exercise (18). However, the 101 
magnitude of alteration in CHO intake required to elicit distinct effects on 102 
muscle glycogen and subsequent metabolic responses to exercise remains 103 
poorly understood. Assessing the magnitude of alteration in CHO intake 104 
required to elicit distinct effects on muscle glycogen and subsequent 105 
metabolic responses to exercise requires several (i.e., >2) experimental 106 
conditions. Three classic studies compared muscle and/or whole-body fuel 107 
use during exercise performed after short-term low (<2.5 g CHO.kg-1.day-1), 108 
moderate (~4-5 g CHO.kg-1.day-1) and/or high (>6.5 g CHO.kg-1.day-1) diet 109 
CHO intake (4, 12, 16). Despite apparent achievement of graded pre-exercise 110 
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muscle glycogen availability, subsequent effects on fuel utilization during 111 
exercise were inconsistent with similar (12, 16) or augmented (4) CHO 112 
oxidation in the high compared to moderate CHO condition. Whilst 113 
informative, these early studies were limited by lack of consistent dietary 114 
control (4, 16) and/or low statistical power to detect differences in fuel 115 
utilization between-conditions (12, 16). As such, the effect of short-term 116 
graded dietary CHO intakes on pre-exercise muscle glycogen, whole-body 117 
and muscle fuel utilization during exercise requires clarification.  118 
 119 
The main aims of the present investigation were to examine the effect of 120 
short-term diet-exercise interventions that provided graded dietary CHO 121 
intake (i.e., ~21% energy intake [EI] or ~2.4 g.kg CHO.kg-1.d-1, ~46%% EI or 122 
~5.0 g.kg CHO.kg-1.d-1, and ~61% EI or ~6.5 g.kg CHO-1.d-1) on pre-exercise 123 
resting muscle glycogen content, muscle and whole-body fuel utilization 124 
during prolonged, moderate-intensity exercise. It was hypothesised that pre-125 
exercise muscle glycogen content and muscle and whole-body fuel utilization 126 
during subsequent moderate-intensity exercise would be graded in line with 127 
the preceding dietary CHO intake. Diet-induced manipulation of fuel utilization 128 
during exercise is likely underpinned by altered systemic (14, 48) and/or local 129 
(i.e. muscle) (42) fuel availability, supported by altered expression of proteins 130 
implicated in up- or down-regulating CHO and fatty acid metabolism (43). 131 
Thus, the expression of selected genes encoding proteins involved in fuel 132 
metabolism was quantified in order to gain further insights into the potential of 133 
skeletal muscle to adapt to varying levels of CHO intake.  134 
  135 
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Materials and methods 136 
Participants 137 
Thirteen recreationally-active males took part in the present investigation 138 
(age, 26 ± 7 y; height, 177.3 ± 7.8 cm; mass, 71.4 ± 7.8 kg; maximum oxygen 139 
uptake [V̇O2max], 49.7 ± 6.7 ml.kg
-1.min-1; data are mean ± standard deviation 140 
[SD]). Participants were required to be aged 18-45 years with a body mass 141 
index of 20-25 kg.m-2 and a V̇O2max of 40-60 ml.kg
-1.min-1. Prospective 142 
participants were excluded if they had known or suspected intolerance or 143 
hypersensitivity to the planned dietary interventions or were taking 144 
medication. All participants provided written informed consent and all 145 
procedures were approved by the Health Research Authority of the United 146 
Kingdom (15/WM/0452). The study was registered at clinicaltrials.gov as 147 
NCT02605291 and conducted in accordance with the Declaration of Helsinki. 148 
 149 
Study design 150 
This study adopted a cross-over design in which participants completed three 151 
four-day diet-exercise interventions in randomised order, with a 1-4 week 152 
intervening washout period (Figure 1). Following an initial assessment to 153 
determine V̇O2max and assess the treadmill speed vs. oxygen consumption 154 
(V̇O2) relationship, participants completed a familiarization to the experimental 155 
protocol. The familiarization period was also used to estimate typical daily 156 
energy expenditure within the intervention periods. The experimental 157 
procedures consisted of 2-d completion of a weighed diet record (day -2 and -158 
1), 1-d consumption of a standardised diet (day 0), and a four-day exercise-159 
diet manipulation (lower, moderate, or higher carbohydrate) finishing with a 160 
Downloaded from journals.physiology.org/journal/jappl at Univ of Exeter Library (144.173.023.152) on May 30, 2021.
7 
 
60-min treadmill run at 65% V̇O2max with heart rate measurement, expired 161 
gas analysis, and venous blood sampling throughout, with pre- and post-162 
exercise muscle biopsies. 163 
 164 
***Insert Figure 1 165 
 166 
Initial assessment 167 
Participants arrived for the initial assessment in the morning after an overnight 168 
fast, having refrained from exercise and alcohol consumption for 24 h. Height 169 
and body mass was recorded prior to an incremental treadmill test to 170 
exhaustion. The test started at 7-10 km.h-1 against a 1% incline, and the 171 
speed was increased by 2 km.h-1 every 4 min for four continuous stages. 172 
Subsequently, the treadmill gradient was increased by 1% every minute until 173 
volitional exhaustion. Breath-by-breath measurements of V̇O2 (Oxycon Pro, 174 
Jaeger, Wuerzberg, Germany) and heart rate (Polar FT-2, Finland) were 175 
obtained throughout. V̇O2 was averaged over the last minute of each 4-min 176 
stage, and linear regression was used to estimate the speed vs. V̇O2 177 
relationship for use in the experimental trials. V̇O2max was calculated as the 178 
highest rolling 60-s average and considered maximal if two of the following 179 
conditions were met: (1) a plateau in V̇O2 despite further increasing workload 180 
(≤2 ml.kg-1.min-1); (2) heart rate ≤10 beats.min-1 of age-predicted maximum 181 
(220 beats.min-1 minus age in years), and (3) respiratory exchange ratio >1.1. 182 
 183 
Familiarization procedures 184 
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Participants returned to the laboratory ~2-7-d following the initial assessment 185 
to begin the familiarization trial. A full familiarization to the experimental 186 
procedures was completed, with the exception of dietary manipulation, muscle 187 
biopsies, and venous blood sampling. In order to estimate free-living energy 188 
expenditure, participants were fitted with an Actiheart (CamNtech Ltd, 189 
Cambridge, UK) at the start of day 1 of familiarization and it remained in place 190 
until the start of day 4 of familiarization. Free-living energy expenditure was 191 
calculated according to manufacturer configurations as the sum of resting 192 
energy expenditure, activity energy expenditure and dietary induced 193 
thermogenesis (estimated as 10% of total energy expenditure). The estimated 194 
EE for Day 1, Day 2, and Day 3 was 3427 ± 1140, 3146 ± 926, and 2621 ± 195 
724 kcal, respectively, which was subsequently used to estimate required 196 
energy intake on each day during subsequent experimental trials in each 197 
volunteer. 198 
 199 
Pre-experimental procedures 200 
The experimental trials commenced with a 3-d pre-trial phase (day -2, -1, and 201 
0). On day -2 and -1, participants recorded a 2-d weighed diet record using 202 
digital weighing scales and blank diaries provided. These diaries were 203 
analysed for energy and macronutrient intake (Dietplan 6.70.67, Forestfield 204 
Software Ltd.) and participants were asked to repeat these diets on day -2 205 
and -1 of subsequent experimental trials. On day 0, participants consumed a 206 
standardised diet provided by the researchers (50% carbohydrate, 35% fat, 207 
and 15% protein, with total energy intake equal to estimated daily energy 208 
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expenditure during familiarization). Participants refrained from exercise on day 209 
-1 and 0. 210 
 211 
Experimental procedures: Glycogen-depleting exercise 212 
On day 1, participants reported to the laboratory after an overnight fast and a 213 
muscle biopsy was obtained from the lateral portion of the vastus lateralis, 214 
~10-15 cm above the patella. Briefly, local anaesthetic was applied to the skin 215 
and fascia, and a 5-mm Bergström needle (6G) was used with suction to 216 
sample ~50-150 mg of muscle tissue through a small incision. On collection, 217 
muscle samples were quickly rinsed with saline, blotted dry, dissected free of 218 
visible fat and connective tissue, separated into 3-4 ~25 mg pieces 219 
(dependent on yield) with some pieces immediately frozen in liquid nitrogen 220 
(for glycogen and gene expression analysis) and one of the pieces embedded 221 
in specialist medium (Tissue Tek® O.C.T.™ Compound, Sakura Finetek 222 
Europe, NET) prior to freezing in liquid nitrogen cooled isopentane (for 223 
intramuscular triglyceride [IMTG] analysis). All muscle was stored at -70°C 224 
until further analysis. Muscle biopsies were only obtained on day 1 in the first 225 
experimental trial to ascertain habitual resting skeletal muscle glycogen and 226 
IMTG content and baseline gene expression. 227 
 228 
Following the biopsy, a standardized breakfast was consumed (one-third of 229 
daily energy intake, 50% carbohydrate, 35% fat, 15% protein). Two 50-min 230 
supervised high-intensity interval sessions were then performed on a 231 
treadmill, separated by 3-4 hours. These sessions involved a 10-min period at 232 
the speed estimated at 70% V̇O2max followed by 5 x 3-min intervals at 90% 233 
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V̇O2max, with 3-min active recovery between-intervals (1.5 min at 25% 234 
V̇O2max and 1.5 min at 50% V̇O2max). A further 10-min period was then 235 
performed at 70% V̇O2max. A low carbohydrate lunch was consumed 236 
between-sessions (one-sixth of daily energy intake, <25% carbohydrate, 237 
>65% fat, 15% protein), and then again following the second interval training 238 
session. A further single interval training session was repeated after an 239 
overnight fast on the morning of day 2. 240 
 241 
Experimental procedures: Dietary manipulation 242 
Participants were randomly allocated to one of three experimental diets, which 243 
were consumed following the second interval session of day 1 and on day 2 244 
and 3 of the protocol. These diets were constructed to be lower (LOW: 245 
carbohydrate, ≤20%; fat, ≥65%; protein, ~15%), moderate (MOD: 246 
carbohydrate, ~50%; fat, ~35%, protein, ~15%), or higher (HIGH: 247 
carbohydrate, ≥65%; fat, ≤20%; protein, ~15%) in carbohydrate. Diets were 248 
isocaloric and total energy intake was equal to estimated daily energy 249 
expenditure determined using heart-rate accelerometry during familiarization. 250 
All diets were prepared by the researchers, and participants were given 251 
written instructions regarding their consumption. The final consumed dietary 252 
intervention characteristics are shown in Table 1. 253 
 254 
***Insert Table 1 255 
 256 
Participants collected all urine output on day 3, and on the morning of day 4, 257 
which was subsequently used to correct substrate oxidation rates (resting 258 
Downloaded from journals.physiology.org/journal/jappl at Univ of Exeter Library (144.173.023.152) on May 30, 2021.
11 
 
only) estimated via gas exchange for urinary nitrogen excretion. Urinary 259 
nitrogen content was estimated by correcting urinary urea and creatinine by 260 
1.11 to account for non-measured nitrogen sources (e.g. ammonia, urate) (5), 261 
and analyzed enzymatically using a semi-automated analyzer (ILab 650, 262 
Instrumentation Laboratory, Bedford, MA) and commercially available kits (IL 263 
Test urea, IL Test creatinine, Instrumentation Laboratories, Cheshire, UK). 264 
 265 
Experimental procedures: Metabolic assessment 266 
On day 4, participants returned to the laboratory after an overnight fast. Post-267 
void body mass was measured and a resting metabolic assessment was 268 
undertaken. Participants lay supine under a ventilated hood connected to an 269 
indirect calorimeter (GEM, GEM Nutrition Ltd, Cheshire, UK) that enabled the 270 
collection of expired gases for estimation of resting whole-body fat and 271 
carbohydrate oxidation using stoichiometric equations (15). An antecubital 272 
venous cannula was then inserted and a 10 mL resting blood sample was 273 
collected. A muscle sample was then obtained from the vastus lateralis 274 
according to the procedures described above. 275 
 276 
Following the resting muscle biopsy, participants ran on a treadmill for 60-min 277 
at 65% V̇O2max. Venous blood (10 mL) and 4-min expired gas samples 278 
(Oxycon Pro, Jaeger, Wuerzberg, Germany) were collected every 20 min 279 
during exercise, and heart rate (Polar Electro Oy, Kemple, Finland) was 280 
collected continuously and recorded every 10 min. Immediately following 281 
exercise, a further muscle sample was obtained from the vastus lateralis. Pre- 282 
and post-exercise biopsies were collected from the same leg within each trial, 283 
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with samples taken at least 2 cm proximal from previous biopsy sites to 284 
minimize the impact of local inflammation from previous sampling. For 285 
consistency, the sampled leg order was standardized between participants 286 
(familiarization – right leg, trial 1 – left leg, trial 2 – right leg, trial 3 – left leg). 287 
 288 
Muscle analysis 289 
For determination of muscle glycogen concentration, duplicate samples of 10-290 
15 mg of frozen muscle were powdered using a pestle and mortar pre-cooled 291 
on dry ice. Thereafter, samples were hydrolyzed by adding 500 μL of 2 mol.L-1 292 
HCl and incubated for 2 h at 95°C. After cooling to room temperature, 293 
samples were neutralized with 500 μL of 2 mol.L-1 NaOH. Samples were then 294 
vortexed, centrifuged (1800 g for 1 minute at 4°C) and the supernatant 295 
analysed in duplicate for glucose concentration using a semi-automatic 296 
analyser (ILab 650, Instrumentation Laboratory, Bedford, MA) and 297 
commercially-available kit (Glucose Oxidase kit, Instrumentation Laboratories, 298 
Cheshire, UK). Muscle glycogen content was taken as the average of the 299 
duplicate muscle samples analysed, with the intra-assay coefficient of 300 
variation <10%. 301 
 302 
Muscle embedded in OCT compound was cryosectioned and analyzed for 303 
Type 1 and 2 muscle fibre specific IMTG (BODIPY D3922, Thermofisher 304 
Scientific, USA) and cytochrome c oxidase 4 (COX4, primary antibody 305 
459600, Thermofisher Scientific, USA) content using immunohistochemical 306 
approaches as described elsewhere (13, 40). BODIPY immunofluorescence 307 
images were captured using a Leica DMIRE2 confocal microscope with a 40x 308 
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oil immersion objective (1,25 NA). COX4 images were captured using a Nikon 309 
E600 microscope coupled to a SPOT RT KE colour three shot CCD camera. 310 
Images were analysed using Image Pro Plus 5.1. 311 
 312 
For analysis of basal muscle gene expression, RNA was extracted from 20-40 313 
mg powdered vastus lateralis tissue using Tri reagent (1 mL, Sigma Aldrich, 314 
UK, T9424) for four samples per participant; baseline, LOW pre-exercise, 315 
MOD pre-exercise and HIGH pre-exercise. Following addition of chloroform 316 
(200 μL, Acros organics 268320025), tubes were mixed vigorously, incubated 317 
at room temperature for 5 min and centrifuged for 10 min at 4°C at 12 000 g. 318 
The RNA phase was mixed with an equal volume of ice cold 70 % ethanol 319 
and RNA was purified on Reliaprep spin columns (Promega, USA, Z6111) 320 
according to the manufacturer’s instructions. The LVis function of the 321 
FLUOstar Omega microplate reader was used to measure RNA concentration 322 
to ensure all samples for each participant had the same amount of RNA (184 323 
ng - 400 ng) reverse transcribed to cDNA using the RT2 First Strand kit 324 
(Qiagen, UK, 330401). Quantitative RT-PCR analysis was performed using 325 
custom designed 384-well RT2 PCR Profiler Arrays (Qiagen) and RT2 SYBR 326 
Green Mastermix (Qiagen) on a CFX384 Real-Time PCR Detection system 327 
(BioRad). 2.8 ng cDNA was added to each well. All primers were 328 
commercially available from Qiagen and Supplementary Table 1 displays the 329 
list of genes analysed alongside their Qiagen catalogue number and Refseq# 330 
(all supplemental material can be found at DOI: 331 
https://doi.org/10.25500/edata.bham.00000609). The absence of genomic 332 
DNA, the efficiency of reverse-transcription and the efficiency of the PCR 333 
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assay were assessed for each sample and conformed to the manufacturer’s 334 
limits in each case. Relative mRNA expression was determined using the 2-335 
∆∆CT method (28). The C(t) values for housekeeper genes beta actin 336 
(Refseq# NM_001101), ribosomal protein lateral stalk subunit P0 (Refseq# 337 
NM_001002) and beta-2-microglobulin (Refseq# NM_004048) showed no 338 
statistical differences between-groups. Therefore the mean C(t) of these three 339 
housekeeper genes was used as an internal control. Data for LOW, MOD and 340 
HIGH is presented as a fold-change from the baseline sample. 341 
 342 
Plasma and serum analysis 343 
Venous blood samples were placed into ethylenediaminetetraacetic acid-344 
containing, lithium-heparin-containing, or serum tubes (BD, New Jersey, USA) 345 
and centrifuged at 1006 g for 15 minutes at 4°C. Plasma or serum was then 346 
extracted and stored in aliquots at -70°C until analysis. All collected samples 347 
were analysed using enzymatic colorimetric assays for glucose (GLU, 348 
Glucose Oxidase kit, Instrumentation Laboratories, Cheshire, UK), non-349 
esterified fatty acids (NEFA, Randox, London, UK), glycerol (GLY, Randox, 350 
London, UK), and lactate (LAC, Randox, London, UK) using a semi-automatic 351 
analyzer (ILab 650, Instrumentation Laboratory, Bedford, MA). Intra-assay 352 
coefficient of variation (CV) was <2.0% for all metabolite assays. Insulin was 353 
analyzed by enzyme-linked immunoassays using a commercially available kit 354 
(Ultra-sensitive Insulin ELISA kit, Human, DRG Diagnostics, Marburg, GER; 355 
CV – 13.5%). Adrenaline and noradrenaline were measured pre- and post-356 
exercise using a commercially available kit (CatCombi ELISA kit, Human, IBL 357 
International, GER; CV – 25.7% and 22.7%, respectively). 358 




Expired gas analysis 360 
V̇O2 and V̇CO2 were used to estimate whole-body rates of carbohydrate and 361 
fat oxidation throughout exercise using the following equations (15): 362 
 363 
Whole-body carbohydrate oxidation (g.min-1) = (4.55 x V̇CO2) – (3.21 x 364 
V̇O2) 365 
 366 
Whole-body fat oxidation (g.min-1) = (1.67 x V̇O2) – (1.67 x V̇CO2) 367 
 368 
Where V̇O2 and V̇CO2 are in L.min
-1. 369 
 370 
Statistical analysis 371 
Statistical procedures were conducted using commercially available software 372 
(SAS Version 9.4, SAS Institute, Cary, NC). Sample size determinations were 373 
made using the pre-exercise muscle glycogen content on Day 4 as the 374 
primary outcome. Based on prior work reporting on glycogen 375 
depletion/repletion patterns with similar exercise-dietary interventions, resting 376 
glycogen was predicted to be highest in HIGH, and ≤70% and ≤40% of that 377 
seen in HIGH with MOD and LOW, respectively (12). Assuming a two-sided 378 
5% significance level, with the use of a within-subject SD of 20 mmol.kg-1 ww 379 
(estimated from published studies reporting resting glycogen content), a 380 
sample size of 12 was required to provide 95% power to detect the 381 
differences predicted (i.e., HIGH vs. MOD, MOD vs. LOW). 382 
 383 
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Data are presented as raw means ± SD, with statistical summaries where 384 
appropriate presented in tabular form. Muscle-related outcomes, substrate 385 
oxidation and plasma catecholamines were assessed using linear mixed 386 
models, with intervention group (LOW, MOD, or HIGH) as fixed effects, and 387 
subject as a random effect. For muscle glycogen and IMTG related-outcomes, 388 
baseline concentration/content recorded on Day 1 of the first intervention 389 
period was included as a covariate. From the models, adjusted means with 390 
95% CIs or standard error (SE) were calculated. In addition, pairwise 391 
differences (HIGH vs. MOD, MOD vs. LOW, and HIGH vs. LOW) were 392 
calculated and presented as 95% CIs and associated unadjusted P-values. 393 
Associations between dietary CHO intake and pre-exercise muscle glycogen, 394 
muscle utilization and fat oxidation during exercise were explored using 395 
Pearson product-moment correlations. For muscle gene expression, in order 396 
to account for multiplicity, adjusted means with 99.95% CIs were calculated 397 
for fold changes relative to baseline, with pairwise differences between 398 
interventions periods calculated and presented as means ± 99.95% CIs and 399 
associated unadjusted P-values. Plasma metabolites and insulin data were 400 
not normally distributed, and these data are presented as means ± SD as 401 
profiles across time with pairwise differences and associated unadjusted P-402 
values determined from Wilcoxon sign rank tests performed on time-averaged 403 
AUC data. Statistical significance was only inferred when unadjusted P-values 404 
met the threshold for significance after Bonferonni adjustment (i.e., 405 
0.05/#comparisons). 406 
  407 




Intervention characteristics 409 
Of the 13 participants who received at least one of the dietary interventions, 410 
10 participants completed all three periods, one completed two of the three 411 
periods (HIGH and LOW) and two participants completed one period (one 412 
HIGH, one MOD). Hence the number of participants completing each of the 413 
dietary interventions was LOW=11, MOD=11, HIGH=12. Participants who did 414 
not contribute any data to a treatment period were not included in that group. 415 
The achieved relative exercise intensity for the 60-min treadmill exercise 416 
bouts was similar between-trials (LOW, 64.6 ± 2.0; MOD, 64.4 ± 2.4, and 417 
HIGH, 64.8 ± 2.5% V̇O2max, P = 0.84). 418 
 419 
Muscle substrate metabolism 420 
Pre-exercise COX4 protein content, as a marker of mitochondrial density, did 421 
not differ in type I (LOW, 26.6 ± 12.9; MOD, 32.7 ± 13.3; HIGH, 31.1 ± 13.2 422 
mean fluorescence intensity per fibre, P = 0.14) or type II (LOW, 20.7 ± 10.7; 423 
MOD, 24.8 ± 10.1; HIGH, 23.6 ± 9.6 mean fluorescence intensity per fibre, P 424 
= 0.20) fibres between-trials. Habitual resting muscle glycogen concentration 425 
was 75.6 ± 18.8 mmol.kg-1 ww, consistent with the lower range of expected 426 
values of participants of similar overall fitness status (2). Pre- and post-427 
exercise muscle glycogen concentrations were significantly lower in LOW vs. 428 
MOD and HIGH, but MOD and HIGH were not significantly different (Figure 429 
2). Net muscle glycogen utilization was not significantly different between-430 
trials, though 95% confidence intervals suggest there was net utilization in 431 
MOD and HIGH but not LOW (Table 2). Dietary CHO during the intervention 432 
Downloaded from journals.physiology.org/journal/jappl at Univ of Exeter Library (144.173.023.152) on May 30, 2021.
18 
 
period was positively associated with pre-exercise muscle glycogen 433 
concentration (r = 0.62, P = 0.0001) but not net muscle glycogen utilization (r 434 
= 0.18, P = 0.32). 435 
 436 
***Insert Figure 2 437 
 438 
Habitual resting IMTG content was 7.33 ± 4.80 and 3.77 ± 2.25 % area lipid 439 
staining for Type 1 and 2 fibres, respectively.  Pre-exercise IMTG content 440 
were not significantly different between-interventions in type I or type II fibres. 441 
Post-exercise IMTG content in type I fibres was significantly greater in LOW 442 
than MOD, but not HIGH, and MOD and HIGH were not significantly different. 443 
Post-exercise IMTG concentration in type II fibres was not significantly 444 
different between-interventions. Net IMTG utilization was not significantly 445 
different between-interventions in type I or type II fibres, however, 95% 446 
confidence intervals suggest there was net IMTG utilization in type I fibres in 447 
LOW and MOD but not HIGH, and in type II fibres in MOD but not LOW or 448 
HIGH (Table 2). 449 
 450 
***Insert Table 2 451 
 452 
Whole-body substrate oxidation rates 453 
Pre-exercise resting whole-body carbohydrate oxidation rate was significantly 454 
greater in HIGH (0.11 ± 0.08 g.min-1) compared to LOW (0.03 ± 0.04 g.min-1, 455 
P < 0.05), whereas no significant differences were observed between LOW 456 
and MOD (0.09 ± 0.07 g.min-1, P = 0.12) or MOD and HIGH (P = 0.53, Figure 457 
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3a). Pre-exercise resting whole-body fat oxidation rates were not significantly 458 
different between-trials (LOW, 0.09 ± 0.04 g.min-1; MOD, 0.08 ± 0.04 g.min-1; 459 
HIGH, 0.07 ± 0.05 g.min-1; P > 0.05, Figure 3b). Whole-body carbohydrate 460 
oxidation during exercise was significantly lower in LOW compared to MOD 461 
and HIGH, but MOD and HIGH were not significantly different (Figure 3a, 462 
Table 3). Whole-body fat oxidation during exercise was significantly greater in 463 
LOW compared to MOD and HIGH, but MOD and HIGH were not significantly 464 
different (Figure 3b, Table 3). Dietary CHO intake during the intervention 465 
period was not significantly associated with whole-body fat oxidation during 466 
exercise (r = -0.26, P = 0.16). 467 
 468 
***Insert Panel Figure 3 469 
 470 
***Insert Table 3 471 
 472 
Blood responses 473 
Blood data is shown in Figure 4 and statistical comparisons are summarized 474 
in Table 4. Pre-exercise blood variables were not significantly different 475 
between-trials, other than plasma lactate concentration being significantly 476 
lower in MOD vs. LOW. Plasma glucose, lactate, NEFA, adrenaline, 477 
noradrenaline and serum insulin concentrations during exercise were not 478 
significantly different between-trials. Plasma glycerol concentrations during 479 
exercise were significantly greater in LOW than MOD and HIGH, whereas 480 
MOD and HIGH were not significantly different.  481 
 482 
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***Insert Panel Figure 4 483 
 484 
***Insert Table 4 485 
 486 
Gene expression 487 
Pre-exercise metabolic gene expression for the 34 genes quantified in LOW, 488 
MOD, and HIGH is shown in Supplementary Table 1, with between-trial 489 
comparisons shown in Supplementary Table 2. Three genes were significantly 490 
different between-trials following correction for multiple comparisons (N = 102, 491 
so P < 0.0005). mRNA expression of FABP3, MLYCD, and UCP3 were all 492 
significantly lower in MOD and HIGH than LOW (Figure 5). With a less 493 
conservative statistical approach, correction for multiple comparisons within 494 
each gene (N = 3), a further seven genes were differentially expressed 495 
between-trials (i.e. P < 0.016). Using this approach, mRNA expression of 496 
ACSL1, PDK2, and PNPLA2 was significantly lower in MOD and HIGH than 497 
LOW, and mRNA expression of CD36, CPT1B, HADHA, and SLC27A1 were 498 
all significantly lower in HIGH than LOW (Supplementary Table 2).  499 
 500 
***Insert Figure 5  501 




The aim of the present investigation was to assess muscle glycogen 503 
availability and muscle and whole-body metabolic responses to moderate-504 
intensity exercise following short-term lower, moderate or higher dietary CHO 505 
intake. Contrary to our hypothesis, graded pre-exercise muscle glycogen 506 
availability was not observed. Rather, the main findings were: 1) pre-exercise 507 
muscle glycogen content was not different between MOD and HIGH; 2) MOD 508 
and HIGH produced broadly similar metabolic responses before and during 509 
subsequent moderate-intensity exercise, and; 3) metabolic responses were 510 
uniquely sensitive to lowered dietary CHO intake. That is, the LOW condition 511 
showed reduced resting muscle glycogen, elevated whole-body fat oxidation 512 
rates and plasma glycerol concentrations during exercise, and increased 513 
skeletal muscle expression of several genes encoding proteins implicated in 514 
fat utilization. 515 
 516 
As stated, and in contrast to our hypothesis (4, 16), HIGH did not produce 517 
significantly greater pre-exercise muscle glycogen concentration than MOD, 518 
despite 1.5 g CHO.kg.day-1 greater CHO ingestion in the preceding 48 h 519 
(Figure 2). Differences in pre-exercise muscle glycogen concentration 520 
between MOD and HIGH could have been observed with greater CHO intake 521 
in HIGH. However, Costill and colleagues (12) observed graded pre-exercise 522 
muscle glycogen using similar CHO intakes as the present study, but applied 523 
over a 24-h recovery period. It is plausible the recovery duration following 524 
glycogen-depleting exercise is influential in the grading of muscle glycogen 525 
concentration to CHO ingestion; the 48 h used in the presented study may 526 
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have been sufficient for muscle glycogen to normalise between MOD and 527 
HIGH at the CHO intakes provided. This contention may be further 528 
substantiated by the graded muscle glycogen observed ~15-16 h following 529 
glycogen-depleting exercise with 0, 3.6, and 7.6 g.kg-1 CHO ingestion in a 530 
more recent study by Hearris and co-workers (21). The absence of 531 
differences in pre-exercise muscle glycogen content could also be attributable 532 
to the aerobic fitness status of the study cohort, given that those with a higher 533 
fitness status have greater capacity for muscle glycogen storage (2). The fate 534 
of the additional CHO provided in HIGH is not readily apparent from the 535 
present data, although oxidation and/or storage as liver glycogen are 536 
possibilities. Regardless, the present data show that when the recovery 537 
duration after successive bouts of high intensity interval exercise is 48 h, 538 
increasing dietary CHO intake from ~5.0 to ~6.5 g CHO.kg-1.day-1 confers no 539 
additional benefit to muscle glycogen storage.   540 
 541 
Consequently, metabolic responses during exercise were similar between 542 
MOD and HIGH, with no clear differences in muscle glycogen use, whole-543 
body substrate oxidation rates, blood variables, or pre-exercise gene 544 
expression (Tables 2-4, Supplementary Table 2). A relatively modest net 545 
muscle glycogen use was seen in the present study (Figure 2, Table 2) which 546 
may be explained by several factors such as the muscle group sampled (i.e., 547 
vastus lateralis shows lower net glycogen use than soleus or gastrocnemius 548 
during level running; (12)), the exercise modality (i.e., net glycogen use in 549 
vastus lateralis is lower in level running than cycle ergometry; (2, 3)) and the 550 
moderate exercise intensity employed (16). Previous work with similar CHO 551 
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intakes in the HIGH condition as the present study reported similar respiratory 552 
exchange ratio (RER) responses to exercise as compared to moderate or 553 
mixed CHO intakes; however, in contrast to the present study, this was 554 
observed despite elevated muscle glycogen availability in the high CHO 555 
conditions (12, 16). With higher rates of CHO ingestion (~8 g CHO.kg-1.d-1), 556 
clearer exercise-metabolic differences have been observed (4). Accordingly, 557 
the addition of the present data to existing literature suggests increasing 558 
short-term CHO intake from ~4.5 to ~6.5 g CHO.kg-1.d-1 (~45 to ~70% EI) in 559 
recovery from exercise does not discernibly influence metabolic responses to 560 
subsequent moderate-intensity exercise (12, 16), and that more aggressive 561 
increases in CHO intake may be required to alter fuel metabolism during 562 
exercise (4). 563 
 564 
In contrast to the largely similar response between MOD and HIGH, 565 
consistent metabolic differences were observed in LOW. This included 566 
lowered pre-exercise muscle glycogen availability (Table 2), decreased CHO 567 
and increased fatty acid oxidation during exercise (Table 3), elevated plasma 568 
glycerol concentrations (Table 4), and up-regulation of several genes 569 
implicated in substrate metabolism, such as FABP3, MLYCD, and UCP3, with 570 
several other genes possibly differentially expressed in LOW 571 
(Supplementary Table 2). These data align with previous research reporting 572 
decreased CHO and increased fatty acid metabolism during exercise 573 
commenced with lowered muscle glycogen (19, 26, 32, 46, 47). It is clearly 574 
plausible reduced muscle glycogen availability contributed to the altered fuel 575 
use per se (18), although it is also possible the additional dietary fat intake 576 
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resulted in adaptations that augmented fatty acid oxidation in LOW (27). 577 
Regardless of the precise mechanism, the present data indicate short-term 578 
CHO intakes of ~2.4 g CHO.kg-1.d-1 (~21% EI) in recovery from exercise are 579 
sufficient to reduce muscle glycogen availability and alter substrate 580 
metabolism during subsequent moderate-intensity exercise, consistent with 581 
what might be expected from studies of non-ketogenic low-CHO, high-fat diets 582 
(7). Whether a ‘threshold’ dietary CHO intake exists, somewhere between 583 
~2.5 and ~4.5 g CHO.kg-1.d-1 (i.e., ~20-45% EI), at which this metabolic shift 584 
takes place requires further investigation.  585 
 586 
The gene expression data demonstrate LOW induced a coordinated change 587 
in basal skeletal muscle gene expression favouring fatty acid utilization, which 588 
is consistent with the metabolic data observed during subsequent moderate-589 
intensity exercise (Supplementary Table 2). Given the 48-h recovery 590 
following the previous exercise bout in the present investigation, this 591 
coordinated change in muscle gene expression can be confidently attributed 592 
to the dietary manipulations (49). Our data align with previous work 593 
demonstrating increased expression of FABP (30), UCP3 (39), PDK2 (11), 594 
CPT1 (3), CD36 (10), and HADHA (30) with low CHO availability. To our 595 
knowledge, a prior nutrient-exercise induced regulation of ACSL1, MLYCD, 596 
PNPLA2, and SLC27A1 gene expression has not previously been shown in 597 
human muscle, but their up-regulation with lower CHO intake is consistent 598 
with an intracellular environment favouring fatty acid utilization. Altered 599 
expression of these genes and/or the proteins they encode for has been 600 
observed after a period of endurance exercise training, a stimulus expected to 601 
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augment the capacity for fatty acid metabolism in skeletal muscle (1, 23, 25, 602 
44). Increased UCP3 gene expression in the present investigation is 603 
interesting in the context of research showing impaired exercise economy 604 
following ingestion of a low CHO-high fat diet (8, 9, 41), given UCP3 is 605 
implicated in uncoupling oxidative phosphorylation from ATP synthesis, and 606 
mitochondrial fatty acid export when supply exceeds oxidation capacity (36–607 
38). Whilst significant between-diet effects on running economy were not seen 608 
in the present investigation (data not shown), possibly due to the low exercise 609 
intensity (41), the data, albeit at the gene level, provide a plausible 610 
mechanism for low-CHO availability-induced impairments in exercise 611 
economy observed elsewhere (8, 9, 41). Collectively, the gene expression 612 
data confirms several previous observations and adds new insights into the 613 
coordinated mRNA response to diet-induced alterations in CHO availability in 614 
humans. 615 
 616 
In summary, the present data demonstrate, within a model of short-term 617 
exercise-diet manipulation, graded metabolic responses to altering dietary 618 
CHO intake do not appear present in the ~5.0-6.5 g CHO.kg-1.d-1 range (46-619 
61% of daily EI). In contrast, more marked reductions in CHO intake (~2.4 620 
g.kg-1.d-1, ~21% EI) lowered resting muscle glycogen concentration, altered 621 
resting expression of genes related to fatty acid utilization in skeletal muscle, 622 
and ultimately increased whole-body fat oxidation during subsequent 623 
moderate-intensity exercise. The data presented herein combined with that of 624 
previous reports suggests that metabolic responses appear somewhat 625 
resistant to short-term dietary CHO change within the 4.5-6.5 g CHO.kg-1.d-1 626 
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(45-70% EI) range (12, 16), but are affected by more aggressive CHO 627 
increases (>6.5 g CHO.kg-1.d-1, >70% EI) or decreases (<2.5 g CHO.kg-1.d-1, 628 
<20% EI) (4). Whether a threshold exists between 4.5 and 2.5 g.CHO.kg-1.d-1 629 
(45%-20% EI) whereby fatty acid metabolism is augmented remains to be 630 
tested. These findings help to provide a useful framework for researchers 631 
when examining responses to exercise-diet manipulations. Furthermore, for 632 
those interested in optimizing fat oxidation, the results provide insights into the 633 
range of moderate to higher short-term CHO intakes within which fat oxidation 634 
is maintained, and highlight the degree of dietary change necessary to induce 635 
clear alterations in in fat oxidation during exercise.    636 
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Table 1. Dietary intervention characteristics 824 
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Table 2. Statistical summary of muscle glycogen and intramuscular 826 
triglycerides concentrations during the 60-min steady-state treadmill running 827 
at 65% V̇O2max in LOW, MOD, and HIGH 828 
 829 
Table 3. Statistical summary of whole-body substrate oxidation rates during 830 
the 60-min steady-state treadmill running at 65% V̇O2max in LOW, MOD, and 831 
HIGH 832 
 833 
Table 4. Statistical summary of plasma and serum concentrations at rest (R) 834 
and during the 60-min steady-state treadmill running at 65%VO2max (Ex) in 835 
LOW, MOD, and HIGH  836 
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Figure headings 837 
 838 
Figure 1. Schematic overview of the experimental design. After two days of 839 
controlled habitual diet consumption, participants undertook successive bouts 840 
of interval running exercise across Days 1 and 2. Isocaloric diets of lower 841 
(LOW), moderate (MOD) and higher (HIGH) carbohydrate (CHO) intakes 842 
were provided across Days 1-3. Metabolic responses to 60-min running at 843 
~65% V̇O2max was assessed on the morning of Day 4, in the overnight fasted 844 
state, and ~48 h after the last exercise bout. A pre-exercise muscle biopsy on 845 
Day 1 was taken on only one occasion. CHO intakes expressed as grams of 846 
CHO per kilogram body mass. 847 
 848 
Figure 2. Muscle glycogen (a) concentration pre- 60-min steady-state 849 
treadmill running at 65% VO2max (mean and individual concentrations) and 850 
(b) net utilization (mean±95% CI) during 60-min treadmill running at 65% 851 
VO2max in LOW, MOD, and HIGH. 852 
 853 
Figure 3. Whole-body rates of (a) carbohydrate and (b) fat oxidation during 854 
60-min steady-state treadmill running at 65% V̇O2max in LOW, MOD, and 855 
HIGH conditions. 856 
 857 
Figure 4. Serum (a) insulin and plasma (b) glycerol, (c) lactate, (d) non-858 
esterified fatty acid concentrations during 60-min treadmill running at 65% 859 
V̇O2max in LOW, MOD, and HIGH conditions. ‘*’ denotes mean exercise AUC 860 
was different in MOD, HIGH vs. LOW (P < 0.05). 861 
 862 
Figure 5. mRNA expression of metabolic genes prior to 60-min steady-state 863 
treadmill running at 65% V̇O2max in LOW, MOD, and HIGH conditions, 864 
expressed as fold-change relative to baseline (day 1 of the first experimental 865 
trial). ‘*’ denotes significantly different vs. LOW (P < 0.0001). 866 
 867 
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Table 1. Dietary intervention characteristics 
 Habitual Day 0 LOW MOD HIGH 
Energy (kcal.d-1) 2250 ± 603 2736 ± 797 3080 ± 917 3084 ± 921 3145 ± 913 
Contribution to energy intake (%) 
CHO 46.9 ± 8.4 48.4 ± 4.0 21.3 ± 0.8 46.3 ± 0.7 60.5 ± 1.6 
Fat 33.3 ± 6.6 33.6 ± 2.8 63.2 ± 1.2 38.3 ± 0.7 24.3 ± 1.8 
Protein 18.4 ± 5.9 14.8 ± 0.7 15.0 ± 0.7 14.8 ± 0.6 14.2 ± 0.8 
Total (g.kg-1.d-1) 
CHO  4.66 ± 1.20 2.40 ± 0.66 4.98 ± 1.31 6.48 ± 1.56 
Fat  1.44 ± 0.40 3.07 ± 0.80 1.89 ± 0.54 1.25 ± 0.36 
Protein  1.42 ± 0.34 1.65 + 0.45 1.60 ± 0.42 1.56 ± 0.40 
Total (g.d-1) 
CHO 267 ± 96 328 ± 93 169 ± 53 322 ± 141 460 ± 124 
Fat 81 ± 21 101 ± 30 215 ± 63 133 ± 42 89 ± 30 
Protein 103 ± 40 100 ± 26 115 ± 35 113 ± 33 111 ± 31 
LOW, MOD and HIGH are calculated from the averages from Day 1-3. Mean ± SD. 
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Table 2. Statistical summary of muscle glycogen and intramuscular triglycerides concentrations during the 60-min steady-state 
treadmill running at 65%VO2max in LOW, MOD, and HIGH 
  Adjusted mean (SE/95% CI) Mean difference (95% CI)


















(mmol.kg-1 ww) P-value - - - 0.0002 0.0004 0.85 
















(mmol.kg-1 ww) P-value - - - 0.15 0.09 0.68 
















(%) P-value - - - 0.55 0.16 0.39 
















(%) P-value - - - 0.03 0.63 0.09 
















(%) P-value - - - 0.24 0.41 0.06 
















(%) P-value - - - 0.21 0.79 0.35 
















(%) P-value - - - 0.34 0.64 0.65 
















(%) P-value - - - 0.07 0.84 0.12 
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Table 3. Statistical summary of whole-body substrate oxidation rates during the 60-min steady-state treadmill running at 
65%VO2max in LOW, MOD, and HIGH 
  Adjusted mean (g.min-1) Mean difference (g.min-1) 



















































 P-value - - - 0.0005 <0.0001 0.14 
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Table 4. Statistical summary of plasma concentrations during the 60-min steady-state treadmill running at 65%VO2max in LOW, 
MOD, and HIGH 
  Median Median difference 





















































































 P-value - - - 0.04 0.02 1.00
  Adjusted mean Mean difference
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(pg.mL-1) P-value - - - 0.41 0.58 0.79 
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Figure 1. Schematic overview of the experimental design. After two days of 
controlled habitual diet consumption, participants undertook successive bouts of 
interval running exercise across Days 1 and 2. Isocaloric diets of lower (LOW), 
moderate (MOD) and higher (HIGH) carbohydrate (CHO) intakes were provided 
across Days 1-3. Metabolic responses to 60-min running at ~65% V̇O2max was 
assessed on the morning of Day 4, in the overnight fasted state, and ~48 h after the 
last exercise bout. A pre-exercise muscle biopsy on Day 1 was taken on only one 
occasion. CHO intakes expressed as grams of CHO per kilogram body mass. 
Day 1 Day 2 Day 3 Day 4 Day 0 Day -1 
LOW 2.40±0.66 g CHO.kg-1.d-1  
MOD 4.98±1.31 g CHO.kg-1.d-1  
HIGH 6.48±1.56 g CHO.kg-1.d-1   
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Figure 2. Muscle glycogen (a) concentration pre- 60-min steady-state 
treadmill running at 65% VO2max (mean and individual concentrations) and 
(b) net utilization (mean±95% CI) during 60-min treadmill running at 65% 


































































































Figure 2. Muscle glycogen (a) concentration pre- 60-min steady-state 
treadmill running at 65% VO2max (mean and individual concentrations) and 
(b) net utilization (mean±95% CI) during 60-min treadmill running at 65% 
VO2max in LOW, MOD, and HIGH. 















































Figure 3. Whole-body rates of (a) carbohydrate and (b) fat oxidation during 60-
min treadmill running at 65%VO2max in LOW, MOD, and HIGH conditions. 
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(b) 
Figure 3. Whole-body rates of (a) carbohydrate and (b) fat oxidation during 60-























































































Figure 4. Serum (a) insulin and plasma (b) glycerol, (c) lactate and (d) non-
esterified fatty acid concentrations during 60-min treadmill running at 65% 
V̇O2max in LOW, MOD, and HIGH conditions. ‘*’ denotes mean exercise AUC was 
different in MOD, HIGH vs. LOW (P < 0.05).  














































Figure 4. Serum (a) insulin and plasma (b) glycerol, (c) lactate and (d) non-
esterified fatty acid concentrations during 60-min treadmill running at 65% 
V̇O2max in LOW, MOD, and HIGH conditions. ‘*’ denotes mean exercise AUC was 
different in MOD, HIGH vs. LOW (P < 0.05).  











































Figure 4. Serum (a) insulin and plasma (b) glycerol, (c) lactate and (d) non-
esterified fatty acid concentrations during 60-min treadmill running at 65% 
V̇O2max in LOW, MOD, and HIGH conditions. ‘*’ denotes mean exercise AUC was 
different in MOD, HIGH vs. LOW (P < 0.05).  

























































Figure 4. Serum (a) insulin and plasma (b) glycerol, (c) lactate and (d) non-
esterified fatty acid concentrations during 60-min treadmill running at 65% 
V̇O2max in LOW, MOD, and HIGH conditions. ‘*’ denotes mean exercise AUC was 
different in MOD, HIGH vs. LOW (P < 0.05).  
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Figure 5. mRNA expression of metabolic genes prior to 60-min steady-state 
treadmill running at 65%VO2max in LOW, MOD, and HIGH conditions, expressed 
as fold-change relative to baseline (day 1 of the first experimental trial) and 





























































* * * * * * 
Downloaded from journals.physiology.org/journal/jappl at Univ of Exeter Library (144.173.023.152) on May 30, 2021.
